TP53 and hepatocellular carcinoma: Moreover, our previous study demonstrated that simvastatin-induced G0/G1 arrest in HCC cells was p53 independent and mediated through inactivation of the STAT3/Skp2 axis via inhibition of the mevalonate pathway13.